Physician profile
Ashley Shell
NPI 1518330018
$13,007.79
in general payments reported to CMS, 2019-2025
26 companies · $2,385 in 2025
The $2,385 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $904 · 2022: $4,034 · 2023: $3,083 · 2024: $2,603 · 2025: $2,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,174 · Travel and Lodging: $1,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,174.48 |
| Travel and Lodging | $1,895.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,764.38 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Abbott Laboratories | $2,721.85 | 2022-2025 | Proclaim |
| Relievant Medsystems, INC. | $1,508.01 | 2023 | Intracept |
| Si-Bone, INC. | $1,386.33 | 2021-2025 | |
| Abbvie INC. | $687.13 | 2021-2025 | |
| Spr Therapeutics, INC | $182.55 | 2022-2023 | Sprint Pns System |
| Globus Medical, INC. | $172.33 | 2025 | Senza |
| Saluda Medical Americas, INC. | $170.44 | 2025 | Evoke |
| Mml US, INC. | $162.09 | 2024 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $146.16 | 2021-2024 | Xtampza |
| Biohaven Pharmaceutical Holding Company Ltd. | $138.37 | 2022 | |
| Nalu Medical, INC. | $134.77 | 2022-2023 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $127.93 | 2023 | Ha Minuteman G3-R |
| Genzyme Corporation | $122.60 | 2023 | |
| Inspire Medical Systems, INC. | $115.29 | 2023 | Inspire |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $100.81 | 2022-2025 | Intracept, General - Pain Management |
| Astrazeneca Pharmaceuticals Lp | $96.94 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.68 | 2021 | |
| Depuy Synthes Sales INC. | $52.69 | 2021-2023 | Monovisc |
| Curonix LLC | $39.04 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $30.87 | 2025 | |
| Acacia Pharma INC | $24.56 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.47 | 2024 | |
| Novartis Pharmaceuticals Corporation | $15.79 | 2021 | |
| International Rehabilitative Sciences, INC | $14.73 | 2024 | Rs 4i Plus Sequential Stimulator |
| Biodelivery Sciences International, INC. | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Shell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.